Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies
- PMID: 33614731
- PMCID: PMC7879293
- DOI: 10.1159/000510513
Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies
Abstract
Background: Previous studies have reported that serum magnesium (Mg) deficiency is involved in the development of heart failure, particularly in patients with end-stage kidney disease. The association between serum Mg levels and mortality risk in patients receiving hemodialysis is controversial. We aimed to estimate the prognostic value of serum Mg concentration on all-cause mortality and cardiovascular mortality in patients receiving hemodialysis.
Methods: We did a systematic literature search in PubMed, EMBASE, Cochrane Library, and Web of Science to identify eligible studies that reported the prognostic value of serum Mg levels in mortality risk among patients on hemodialysis. We performed a meta-analysis by pooling and analyzing hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: We identified 13 observational studies with an overall sample of 42,967 hemodialysis patients. Higher all-cause mortality (adjusted HR 1.58 [95% CI: 1.31-1.91]) and higher cardiovascular mortality (adjusted HR 3.08 [95% CI: 1.27-7.50]) were found in patients with lower serum Mg levels after multivariable adjustment. There was marked heterogeneity (I2 = 79.6%, p < 0.001) that was partly explained by differences in age stratification and study area. In addition, subgroup analysis showed that a serum Mg concentration of ≤1.1 mmol/L might be the vigilant cutoff value.
Conclusion: A lower serum Mg level was associated with higher all-cause mortality and cardiovascular mortality in patients receiving hemodialysis.
Keywords: Hemodialysis; Meta-analysis; Mortality; Serum magnesium.
Copyright © 2020 by S. Karger AG, Basel.
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
Figures





Similar articles
-
Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.J Nephrol. 2019 Oct;32(5):791-802. doi: 10.1007/s40620-019-00601-6. Epub 2019 Mar 19. J Nephrol. 2019. PMID: 30888644
-
Elevated serum uric acid and risk of cardiovascular or all-cause mortality in maintenance hemodialysis patients: A meta-analysis.Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):372-381. doi: 10.1016/j.numecd.2020.11.017. Epub 2020 Nov 25. Nutr Metab Cardiovasc Dis. 2021. PMID: 33485730
-
A Systematic Review and Meta-Analysis: Hyponatremia Predicted All-Cause and Cardiovascular Mortality in Dialysis Population.Blood Purif. 2022;51(4):345-354. doi: 10.1159/000517340. Epub 2021 Jul 20. Blood Purif. 2022. PMID: 34284380
-
Blood Pressure Variability and Prognosis in Hemodialysis Patients: A Systematic Review and Meta-Analysis.Kidney Dis (Basel). 2021 Sep;7(5):411-424. doi: 10.1159/000511295. Epub 2020 Nov 10. Kidney Dis (Basel). 2021. PMID: 34604346 Free PMC article.
-
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.Magnes Res. 2007 Dec;20(4):237-44. Magnes Res. 2007. PMID: 18271493
Cited by
-
Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease.J Clin Med. 2022 Sep 28;11(19):5746. doi: 10.3390/jcm11195746. J Clin Med. 2022. PMID: 36233612 Free PMC article.
References
-
- He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006 Apr;113((13)):1675–82. - PubMed
-
- Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr. 2012 Feb;95((2)):362–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources